[The procedure for using Renitec (an angiotensin-converting enzyme inhibitor) for the treatment and prevention of diabetic nephropathy].
Shestakova
M V
MV
Sheremet'eva
S V
SV
Dedov
I I
II
D000293:Adolescent; D002908:Chronic Disease; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D004656:Enalapril / Q000008:administration & dosage*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology
D004656:Enalapril; D006442:Glycated Hemoglobin
Taktika primeneniia reniteka (ingibitora angiotenzinprevrashchaiushchego fermenta) dlia lecheniia i profilaktiki diabeticheskoĭ nefropatii.